Lv1
50 积分 2026-06-30 加入
HAEMOPHILIA 2025 Vol. 31 Pages 60-61
1个月前
已关闭
Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial
1个月前
已关闭
Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study
1个月前
已关闭
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
1个月前
已完结
Concizumab use in toddlers with hemophilia B and inhibitors real-world data from an international collaboration
1个月前
已完结
Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)
1个月前
已完结
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
1个月前
已关闭
Patient Experience with Mim8 Prophylaxis: 52-Week Patient-Reported Outcomes in Adolescents and Adults with Haemophilia A (FRONTIER2)
1个月前
已关闭
皖公网安备34019202002308
